Landiolol, an intravenous β1‐selective blocker, is useful for dissociating a fusion of atrial activation via accessory pathway and atrioventricular node
Ontology highlight
SUBMITTER: Kinjo T
PROVIDER: S-EPMC10692861 | biostudies-literature | 2023 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA